Rhythm Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Rhythm Pharmaceuticals, Inc.‘s stocks are currently a part of 109 hedge funds’ portfolios, which represents 98.42% of the total amount of its stocks outstanding. This makes up a total of 48.81M shares of Rhythm Pharmaceuticals, Inc.. Compared to the previous quarter, the number grew by 0.79% or 381.43K shares more. As for the holding position changes, 28.44% (31) of current hedge fund investors increased the number of shares held, 33.03% (36) of current holders sold a part of the shares held, and 6.42% (7) closed the holdings completely. 23 hedge funds are new holders of Rhythm Pharmaceuticals, Inc. stock in Q1 2022, it is 21.1% of total holders.
Hedge funds holding Rhythm Pharmaceuticals (Q4 2017 – Q1 2022)
| Q4 2017 | 66 |
|---|---|
| Q1 2018 | 54 |
| Q2 2018 | 85 |
| Q3 2018 | 78 |
| Q4 2018 | 73 |
| Q1 2019 | 85 |
| Q2 2019 | 83 |
| Q3 2019 | 85 |
| Q4 2019 | 89 |
| Q1 2020 | 80 |
| Q2 2020 | 91 |
| Q3 2020 | 114 |
| Q4 2020 | 118 |
| Q1 2021 | 122 |
| Q2 2021 | 103 |
| Q3 2021 | 94 |
| Q4 2021 | 94 |
| Q1 2022 | 109 |
Hedge funds changes in Rhythm Pharmaceuticals positions (Q4 2017 – Q1 2022)
| Q4 2017 | 66 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q1 2018 | 5 | 19 | 16 | 17 | -3 |
| Q2 2018 | 35 | 38 | 9 | 4 | -1 |
| Q3 2018 | 10 | 38 | 21 | 17 | -8 |
| Q4 2018 | 10 | 31 | 22 | 15 | -5 |
| Q1 2019 | 17 | 28 | 24 | 5 | 11 |
| Q2 2019 | 13 | 36 | 15 | 13 | 6 |
| Q3 2019 | 15 | 29 | 26 | 13 | 2 |
| Q4 2019 | 19 | 43 | 16 | 15 | -4 |
| Q1 2020 | 15 | 27 | 22 | 23 | -7 |
| Q2 2020 | 21 | 38 | 18 | 10 | 4 |
| Q3 2020 | 32 | 25 | 38 | 9 | 10 |
| Q4 2020 | 18 | 37 | 40 | 14 | 9 |
| Q1 2021 | 25 | 59 | 24 | 19 | -5 |
| Q2 2021 | 7 | 42 | 32 | 25 | -3 |
| Q3 2021 | 6 | 29 | 34 | 15 | 10 |
| Q4 2021 | 11 | 39 | 28 | 12 | 4 |
| Q1 2022 | 23 | 31 | 36 | 7 | 12 |
Hedge funds changes in Rhythm Pharmaceuticals stock options (Q4 2017 – Q1 2022)
| Q4 2017 | 0 | 0 |
|---|---|---|
| Q1 2018 | 0 | 0 |
| Q2 2018 | 0 | 0 |
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 214,000 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 1,000 | 19,000 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 892,000 | 1,863,000 |
| Q4 2020 | 3,315,000 | 5,807,000 |
| Q1 2021 | 1,050,000 | 1,391,000 |
| Q2 2021 | 68,000 | 800,000 |
| Q3 2021 | 715,000 | 264,000 |
| Q4 2021 | 154,000 | 90,000 |
| Q1 2022 | 4,228,000 | 272,000 |